Defining the mechanistic basis of ATM’s impact on VDJ recombination
Defining the mechanistic basis of ATM’s impact on VDJ recombination
批准号:
10392873
负责人:
Katheryn D Meek
金额:
$38.75万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-05-20 至 2025-04-30
关键词:
ATM deficientAblationAffectAlanineAntibodiesAntigen ReceptorsAtaxia TelangiectasiaAtaxia Telangiectasia PatientsAtrophicBiochemicalBiological AssayCancer EtiologyCell LineCell modelCellsCellular AssayCodeComplexCultured CellsDNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA-dependent protein kinaseDataDefectDevelopmentDiseaseExonsGene PoolGenesGenetic RecombinationGenomeGenomic InstabilityGenomicsGrowthHumanImmuneImmune System DiseasesIn VitroInfertilityLymphocyteMalignant lymphoid neoplasmModelingMusNonhomologous DNA End JoiningOccupationsPathway interactionsPhenotypePhosphorylationPhosphorylation SitePhosphotransferasesPredispositionPremature aging syndromeProcessRAG1 geneRag1 MouseResearchResistanceResolutionRoleSignal TransductionSiteStructureT-Cell ReceptorT-LymphocyteTelangiectasisV(D)J Recombinationaccess restrictionsadaptive immune responseataxia telangiectasia mutated proteinendonucleaseexperimental studyin vivolymphoid neoplasmmutantpathogenpreventreceptorrepairedresponserestraintvirtual
中文摘要
项目摘要
ATM激酶是DNA损伤反应的核心;因此,这种大激酶是调节DNA损伤的核心。
在VDJ重组过程中,发育中的淋巴细胞如何对自身施加的DNA损伤作出反应。虽然
证据是压倒性的和明确的,ATM有助于精确的非同源末端连接,
VDJ编码片段,并抑制其参与基因组易位,这是一个明确的机制,
对ATM实际上是如何完成这项工作的了解还很缺乏。
最近,我们发现在许多培养的细胞株中ATM消融导致附加体中VDJ连接增加,
如果ATM在末端连接中具有直接的功能作用,则这是完全违反直觉的结果。我们
认为如果ATM的作用是调节RAG后切割复合物,ATM的丢失可能
导致VDJ重组中间体的释放增加和更快的连接,解释了VDJ重组中间体的增加。
观察到的重组。我们微调了检测方法,使结构/功能,还原主义的方法可以
用于描述ATM是否以及如何直接影响RAG复合体。我们发现ATM信号抑制
连接需要RAG 1和RAG 2的非核心C-末端。这促使人们对这些地区进行了研究
潜在的ATM/DNA-PK靶位点。屏蔽这些站点不仅可以屏蔽ATM对信号接入的影响,
细胞试验中,它也消除了RAG 1/RAG 2在高度纯化和全功能RAG上的稳健磷酸化
通过ATM和DNA-PK在体外的复合物。这些数据支持我们的模型,ATM直接调节VDJ
通过RAG复合物的磷酸化进行重组。本申请中提出的实验将使用
生物化学方法来定义ATM如何影响切割和信号末端释放,并将使用细胞
染色体VDJ重组模型,以进一步确定ATM如何调节VDJ重组。
英文摘要
Project Summary
The ATM kinase is central to the DNA damage response; it follows that this large kinase is central to regulating
how developing lymphocytes respond to their self-imposed DNA damage during VDJ recombination. Although
the evidence is overwhelming and unequivocal that ATM contributes to accurate non-homologous end joining of
VDJ coding segments, and restrains their participation in genomic translocations, a clear mechanistic
understanding of how ATM actually does this job is lacking.
Recently, we found that ATM ablation in many cultured cell strains results in increased VDJ joining in episomal
assays, a completely counter-intuitive result if ATM were to have a direct functional role in end joining. We
considered that if ATM's role was instead, to regulate the RAG post cleavage complex(s), loss of ATM might
result in increased release of VDJ recombination intermediates and more rapid joining, explaining the increased
recombination observed. We fine-tuned the assay so that a structure/function, reductionist approach could be
employed to delineate if and how ATM directly affects the RAG complex. We find that ATM inhibition of signal
joining requires the non-core C-termini of both RAG1 and RAG2. This prompted an examination of these regions
for potential ATM/DNA-PK target sites. Blocking these sites not only blocks ATM's effect on signal joining in
cellular assays, it also ablates robust phosphorylation of RAG1/RAG2 on highly purified and fully functional RAG
complexes by ATM and DNA-PK in vitro. These data support our model that ATM directly regulates VDJ
recombination by phosphorylation of the RAG complex. The experiments proposed in this application will use
biochemical approaches to define how ATM affects cleavage and signal end release, and will use a cellular
model of chromosomal VDJ recombination to further define how ATM regulates VDJ recombination.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
An insulator that regulates chromatin extrusion and class switch recombination.
调节染色质挤出和类别转换重组的绝缘体。
DOI:
10.1073/pnas.2026399118
发表时间:
2021
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Yu,Kefei]
通讯作者:
Yu,Kefei
DOI:
10.1016/j.molcel.2021.07.005
发表时间:
2021-08-19
期刊:
MOLECULAR CELL
影响因子:
16
作者:
[Chaplin, Amanda K., Hardwick, Steven W., Stavridi, Antonia Kefala, Buehl, Christopher J., Goff, Noah J., Ropars, Virginie, Liang, Shikang, De Oliveira, Taiana Maia, Chirgadze, Dimitri Y., Meek, Katheryn, Charbonnier, Jean-Baptiste, Blundell, Tom L.]
通讯作者:
Blundell, Tom L.
DOI:
10.1093/nar/gkac913
发表时间:
2022-10-28
期刊:
NUCLEIC ACIDS RESEARCH
影响因子:
14.9
作者:
[Goff, Noah J., Breniere, Manon, Buehl, Christopher J., de Melo, Abinadabe J., Huskova, Hana, Ochi, Takashi, Blundell, Tom L., Mao, Weifeng, Yu, Kefei, Modesti, Mauro, Meek, Katheryn]
通讯作者:
Meek, Katheryn
Unravelling the complexities of DNA-PK activation by structure-based mutagenesis.
通过基于结构的诱变揭示 DNA-PK 激活的复杂性。
DOI:
10.21203/rs.3.rs-3627471/v1
发表时间:
2023
期刊:
Research square
影响因子:
--
作者:
[Buehl,ChristopherJ, Goff,NoahJ, Mikhova,Mariia, Hardwick,StevenW, Blundell,ThomasL, Modesti,Mauro, Schmidt,JensC, Chaplin,Amanda, Meek,Katheryn]
通讯作者:
Meek,Katheryn
DOI:
10.1016/j.molcel.2021.11.025
发表时间:
2022-01-06
期刊:
Molecular cell
影响因子:
16
作者:
[Liu L, Chen X, Li J, Wang H, Buehl CJ, Goff NJ, Meek K, Yang W, Gellert M]
通讯作者:
Gellert M
共 6 条
Does overexpression of DNA polymerase theta sensitize cancers to G-quadruplex binding drugs?
-
批准号:9807624
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2019
-
负责人:Katheryn D Meek
-
依托单位:
A NEW ANIMAL MODEL OF SCID FOR BIOMEDICAL RESEARCH
-
批准号:6895183
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2002
-
负责人:Katheryn D Meek
-
依托单位:
A NEW ANIMAL MODEL OF SCID FOR BIOMEDICAL RESEARCH
-
批准号:6542395
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2002
-
负责人:Katheryn D Meek
-
依托单位:
A NEW ANIMAL MODEL OF SCID FOR BIOMEDICAL RESEARCH
-
批准号:7086893
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2002
-
负责人:Katheryn D Meek
-
依托单位:
A NEW ANIMAL MODEL OF SCID FOR BIOMEDICAL RESEARCH
-
批准号:6609666
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2002
-
负责人:Katheryn D Meek
-
依托单位:
A NEW ANIMAL MODEL OF SCID FOR BIOMEDICAL RESEARCH
-
批准号:6771776
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2002
-
负责人:Katheryn D Meek
-
依托单位:
MECHANISTIC ANALYSIS OF PREFERENTIAL DHRSS TARGETING
-
批准号:6484671
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2001
-
负责人:Katheryn D Meek
-
依托单位:
FUNCTIONAL ANALYSES OF DNA PKCS AND ITS SPLICE VARIANTS
-
批准号:6042068
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:6572093
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:6848684
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:6703702
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Defining relevant targets of the DNA dependent protein kinase
-
批准号:8435667
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Defining relevant targets of the DNA dependent protein kinase
-
批准号:8662140
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
MECHANISTIC ANALYSIS OF PREFERENTIAL DHRSS TARGETING
-
批准号:6344600
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Defining Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:7387774
-
项目类别:
-
资助金额:$37.94万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Defining Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:8036041
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
MECHANISTIC ANALYSIS OF PREFERENTIAL DHRSS TARGETING
-
批准号:6216428
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Defining Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:7777792
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
Relevant Targets of the DNA Dependent Protein Kinase
-
批准号:7189878
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
FUNCTIONAL ANALYSES OF DNA PKCS AND ITS SPLICE VARIANTS
-
批准号:6511405
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2000
-
负责人:Katheryn D Meek
-
依托单位:
海外基金